Skip to main content

Table 4 Cox Regression of Factors Associated with Mortality, DMMS WAVE 2 patients with HIVAN only

From: HIVAN and medication use in chronic dialysis patients in the United States: analysis of the USRDS DMMS Wave 2 study

  One-Year Unadjusted Survival Factor Present One-Year Unadjusted Survival Factor Absent P Value AHR 95% CI
African American Race* (vs. all other races) 54% 40% 0.05 0.20 0.04, 0.99
  Two-Year Unadjusted Survival Two-Year Unadjusted Survival    
Antiretroviral therapy (yes/No) 15% 39% 0.21 1.92 0.69, 5.37
Multiple antiretroviral agents (yes/No) 22% 33% 0.60 0.62 0.10, 3.86
ACE inhibitors (vs. nonuse) 13% 29% 0.28 2.26 0.55, 9.31
CCB (vs. nonuse) 42% 25% 0.36 0.56 0.16, 1.96
Male (vs. female) 33% 17% 0.31 0.44 0.09, 2.16
Peritoneal Dialysis (vs. Hemodialysis) 38% 26% 0.47 0.58 0.13, 2.53
  1. N = 36, N in final model = 30 *Because so few patients with HIVAN were not African American, only one-year survival could be compared Only factors significant in the final model are shown.